Pulsed Electric Field Ablation for Pancreatic Cancer

This trial tests a new, minimally invasive treatment for pancreatic cancer that uses electric pulses to destroy tumor cells. It targets individuals with pancreatic cysts or certain small tumors who are not suitable candidates for surgery. Known as Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation, the treatment uses a tiny needle to deliver electric bursts, targeting and killing tumor cells while sparing healthy tissue. Patients diagnosed with a pancreatic neoplasm, such as a cyst or small tumor, who cannot undergo surgery might be suitable candidates.

As an unphased trial, this study provides patients with access to innovative treatment options that could potentially improve their condition.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

Research has shown that endoscopic ultrasound-guided pulsed electric field ablation might safely and effectively treat pancreatic tumors. Early results indicate that patients generally tolerate this treatment well. The procedure uses quick bursts of electricity to target and destroy tumor cells while sparing nearby healthy tissue. This approach reduces the risk of damaging critical areas around the tumor, potentially making it safer than more invasive treatments.

Unlike the standard care options for pancreatic cancer, such as surgery, chemotherapy, and radiation therapy, Pulsed Electric Field (PEF) ablation offers a unique approach. This treatment uses short bursts of electric fields to disrupt cancer cell membranes, leading to cell death without the need for incisions or systemic drugs. Researchers are excited about PEF ablation because it targets tumors directly with minimal damage to surrounding healthy tissue, which may reduce side effects and improve recovery times. Additionally, this method is delivered via endoscopic ultrasound, which allows precise targeting of the tumor, potentially enhancing treatment efficacy.

Research has shown that pulsed electric field ablation offers promise as a treatment for pancreatic cancer. This method uses strong electrical bursts to destroy cancer cells while sparing healthy tissue. Early findings suggest it can serve as a safer, less invasive alternative to surgery. In some studies, patients experienced smaller tumors and better outcomes when this treatment was combined with chemotherapy. Although researchers continue to study the technique, early results encourage those seeking new ways to manage pancreatic cancer. Participants in this trial will undergo endoscopic ultrasound-guided pulsed electric field ablation to further evaluate its effectiveness.¹²⁴⁵⁶